Sarcomatrix Therapeutics Appoints Dr. Jeff Myers as Chief Medical Officer
A veteran biopharma executive and former cardiothoracic surgeon is joining the company as its lead candidate S-969 progresses toward an IND submission. RENO, NV, UNITED STATES, July 17, 2026 /EINPresswire.com/...
By Samuel Reed · Jul. 17, 2026